vimarsana.com

Scientific Co Founders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stellaromics secures $25 million in series a funding to advance 3D spatial multi-omic profiling

Stellaromics today announced that the company has raised $25 million in a Series A financing round.

Xiao wangKarl deisserothTodd dickinsonTechnology access programStellaromics scientific coPlaisance capital managementBionano genomicsCantata bioDovetail genomicsArc bioNature chemical biologyScientific co foundersSpatially resolved transcript amplicon readoutInfectious diseases

2023-10-23 | NDAQ:BYSI | Press Release | Beyondspring Inc

(2023-10-23 | NDAQ:BYSI) SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors

United statesJackson taiLinus linOmelveny myersKo yung tungBeyondspring closecurlyquoteJames tonraEli lillyMorrison foersterEisai co ltdHarvard law schoolInternational businessHarvard collegeCounsel of the world bankGlobal health innovative technology fundCouncil on foreign relations

EXCLUSIVE: Ocean Biomedical Announces New Patent For Fibrosis Candidate Catering To One Of Leading Death Causes In US - Ocean Biomedical (NASDAQ:OCEA)

Ocean Biomedical Inc (NASDAQ: OCEA) announced that the United States Patent and Trademark Office has issued a patent covering Ocean’s anti-Chitinase 1 small molecule candidate. 

United statesJack eliasJacka eliasTrademark officeOcean biomedicalUnited states patentScientific co foundersCompositions relatingHermansky pudlak syndrome

Ocean Biomedical (NASDAQ: OCEA) Announces New Patent for Anti-Fibrosis Discovery with Allowance in Alcoholic Liver Disease and Multiple Fibrotic Conditions, Leading Causes of Death in the U S Seite 1

29.08.2023 - Ocean’s small molecule candidate significantly controls fibrosis progression in idiopathic pulmonary fibrosis (IPF) and Hermansky-Pudlak Syndrome (HPS) in multiple testing models. Patent granted for use in IPF, HPS, alcoholic liver disease, . Seite 1

Jacka eliasScientific co foundersHermansky pudlak syndromeCompositions relatingOcean biomedical chartCean biomedical kursCean biomedical aktie

Ocean Biomedical (NASDAQ: OCEA) Share Price Target Now

Ocean Biomedical will host a Research and Development Day, Live Q&A with Scientific Co-founders, Dr. Jack A. Elias, MD and Dr. Jonathan Kurtis, MD, PhD.

United statesKevin kertscherChirinjeev kathuriaJonathan kurtisGurinder kalraJacka eliasResearch corporationWhite lion capitalAlto opportunity master fundOcean biomedical incDevelopment dayCommunications directorCompany annual report on formCompany commentOcean biomedicalScientific co founders

vimarsana © 2020. All Rights Reserved.